LDLR and atherosclerosis: Moreover, PD-1/PD-L1 deficiency aggravates experimental atherosclerosis in LDL receptor deficient (Ldlr−/−) mice (20–22), with increased numbers of pro-atherogenic CD4+ and CD8+ T cells in the plaque.